Feasibility Study of Navigated Endoscopy for the Placement of High Dose Rate Brachytherapy Applicators in the Esophagus and Lung
NCT03051802 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1
Last updated 2018-05-24
Summary
The scope of this clinical trial is to assess the clinical feasibility of this procedure, optimize the protocol and perform an initial comparison of the positional accuracy of navigated endoscopy and applicator insertion versus the standard of care 2D fluoroscopy protocol.
Conditions
- Esophagus Cancer
- Lung Cancer
Interventions
- DEVICE
-
Navigated Endoscopy
Navigated endoscopy used to guide the placement of HDR applicators in the esophagus or lung as a replacement to current standard of practice using fluoroscopic imaging.
Sponsors & Collaborators
-
University Health Network, Toronto
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DEVICE_FEASIBILITY
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-27
- Primary Completion
- 2018-04-24
- Completion
- 2018-04-24
Countries
- Canada
Study Locations
More Related Trials
-
Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal Cancer
NCT03234842 ·Status: WITHDRAWN ·Phase: PHASE2
-
Proton Beam Therapy in the Treatment of Esophageal Cancer
NCT03482791 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
NCT03801876 ·Status: RECRUITING ·Phase: PHASE3
-
Dose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real Dose
NCT02130011 ·Status: COMPLETED ·Phase: NA
-
Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy
NCT07164690 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus
NCT01238042 ·Status: COMPLETED ·Phase: PHASE1
-
Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia
NCT00665197 ·Status: COMPLETED ·Phase: PHASE3
-
Intermittent Oral-esophageal Tube Feeding in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma
NCT06189482 ·Status: TERMINATED ·Phase: NA
-
Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
NCT02642809 ·Status: COMPLETED ·Phase: PHASE1
-
Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer
NCT02830594 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
NCT00561197 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
NCT04615013 ·Status: RECRUITING ·Phase: PHASE1
-
Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer
NCT03094884 ·Status: UNKNOWN ·Phase: PHASE1
-
Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.
NCT06020885 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma
NCT06248840 ·Status: TERMINATED ·Phase: NA
-
Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer
NCT02213497 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Chemoradiotherapy for Advanced Esophageal Cancer
NCT02297217 ·Status: RECRUITING ·Phase: PHASE2
-
Induction FLOT With CROSS CRT for Esophageal Cancer
NCT04028167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery
NCT05713838 ·Status: RECRUITING ·Phase: PHASE2
-
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer
NCT00632333 ·Status: UNKNOWN ·Phase: PHASE1
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00002631 ·Status: COMPLETED ·Phase: PHASE3
-
Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma
NCT07182565 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Endoesophageal Brachytherapy for Patients With Esophageal Cancer
NCT03335813 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography in Determining Stage of Esophageal Cancer
NCT00004867 ·Status: COMPLETED ·Phase: NA
-
S-1 and Radiotherapy for Elderly Esophageal Cancer Patients
NCT02716688 ·Status: WITHDRAWN ·Phase: PHASE2